New anesthesia approach may speed recovery in lung cancer surgery

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age ≤ 75 years; * Gender is not limited; * Patients with suspected T1 stage non-small cell lung cancer (NSCLC) in preoperative clinical staging, with thin-slice CT showing that the maximum tumor diameter is ≤ 3.0 cm, single or multiple nodules, and the nodules requiring surgical resection are located in the same ipsilateral lung lobe, with the number of nodules resected simultaneously ≤ 3; * American Society of Anesthesiologists (ASA) classification ≤ Grade III (preferably Grade I - II is recommended); * Eastern Cooperative Oncology Group (ECOG) performance status 0 - 1; * Body Mass Index (BMI) \< 25 kg·m-²; * Normal cardiopulmonary function: predicted forced expiratory volume in the first second (FEV1%) \> 50%, resting blood gas analysis showing arterial oxygen partial pressure (PaO2) ≥ 75 mmHg, arterial carbon dioxide partial pressure (PaCO2) \< 45 mmHg; ejection fraction (EF) \> 50%, 6-minute walk distance (6MWD) ≥ 350 m; * No severe upper airway lesions, Mallampati classification I - II; * No contraindications related to paravertebral nerve block and intercostal nerve block; * Estimated surgical time ≤ 150 minutes; * Patients have no history of clinically significant cardiac or neurological problems. Exclusion Criteria: * A history of ipsilateral lung surgery; * Interstitial pneumonia, pulmonary fibrosis, severe emphysema, severe chronic obstructive pulmonary disease, acute phase of pulmonary infection, or uncontrolled asthma; * Sleep apnea syndrome with anticipated airway difficulty or difficulty in airway management; * Preoperative complications including coagulation dysfunction, hypoxemia, hypercapnia, or hepatic/renal insufficiency; * Alteration of anesthesia or surgical plan; * Persistent cough or increased risk of high airway secretion reflux; * Mental disorders, inability to communicate, or refusal to sign the informed consent form; * Participation in other clinical trials within 1 month before this trial; * Those who are deemed unfit to participate in this trial by the researchers.